What is Wooptix?
Founded in 2016 and headquartered in Tenerife, Spain, Wooptix is a pioneering entity in WaveFront Phase Imaging (WFPI) technology. Originating from astrophysics research, the company has successfully adapted its sophisticated imaging techniques for critical applications across semiconductor metrology, ophthalmology, and 3D imaging. With a strategic presence in Madrid and San Francisco, Wooptix actively engages with leading research institutions to advance the frontiers of high-precision optical measurement and imaging solutions. This focus positions Wooptix at the intersection of cutting-edge scientific research and practical industrial application.
How much funding has Wooptix raised?
Wooptix has raised a total of $24.8M across 3 funding rounds:
Series A
$3.3M
Series B
$11M
Series C
$10.5M
Series A (2016): $3.3M with participation from Caixa Capital Risc and Intel Capital
Series B (2023): $11M led by Bullnet Capital, Danobat, and The European Innovation Council
Series C (2025): $10.5M supported by Intel Capital, EIC Solutions, and Samsung Ventures
Key Investors in Wooptix
Intel Capital
Intel Capital, a division of Intel, invests in innovative startups across various technology sectors including AI, autonomous vehicles, and cloud computing. They focus on identifying and supporting companies with next-generation compute potential.
Bullnet Capital
Bullnet Capital is a venture capital firm that specializes in high-technology Spanish startups, providing support for early-stage companies with disruptive technologies and entrepreneurial teams.
Samsung Ventures
Samsung Ventures invests in promising small and medium-sized companies focused on new technologies, aiming to foster future growth engines through managerial expertise and strategic partnerships.
What's next for Wooptix?
The recent major strategic investment in Wooptix signals a pivotal phase for the company, likely enabling accelerated product development, market expansion, and further research into WFPI technology's diverse applications. This capital infusion is expected to bolster Wooptix's competitive edge in the semiconductor, medical, and 3D imaging sectors, potentially leading to new partnerships and technological breakthroughs. The company's trajectory suggests a strong emphasis on scaling its operations and solidifying its position as a leader in advanced optical imaging.
See full Wooptix company page
